Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis

Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2024-11, Vol.735, p.150651, Article 150651
Hauptverfasser: Feng, Furui, Li, Xinyu, Wang, Wenbin, Dou, Mengmeng, Li, Silu, Jin, Xin, Chu, Yaojuan, Zhu, Lin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 150651
container_title Biochemical and biophysical research communications
container_volume 735
creator Feng, Furui
Li, Xinyu
Wang, Wenbin
Dou, Mengmeng
Li, Silu
Jin, Xin
Chu, Yaojuan
Zhu, Lin
description Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE. •Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.
doi_str_mv 10.1016/j.bbrc.2024.150651
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154159323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X24011872</els_id><sourcerecordid>3103445590</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</originalsourceid><addsrcrecordid>eNqNkU1P3DAURS1UBMPHH2CBsuwmw7OdeGKJDUK0RaLqBiR2luO8zHjkxKntVPDv69FMWaKu3ubcK717CLmisKRAxc122bbBLBmwaklrEDU9IgsKEkpGofpCFgAgSibp6yk5i3ELQGkl5Ak55ZIJ4JwviPupU7AjFlPwCU2KhV5rO8ZU4NuEwQ44Ju0KPSdvh2HOII4Gp412fnhHZ5ONRdoEP683xeC72elkx3UxWBP82tkc7TEEPyUfbbwgx712ES8P95y8fHt4vv9RPv36_nh_91QatoJUtpxyCW3dr6iWIA1vddXU0gBrWiOAgdENW1VSG95kxHRMtNqIvpemEVoIfk6-7nvzU79njEkNNhp0To_o56g4rStaS874f6DAq6quJWSU7dH8WowBezXlfXR4VxTUTojaqp0QtROi9kJy6PrQP7cDdh-RfwYycLsHMA_yx2JQ0djdxp0N2YfqvP2s_y8SKZ7R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3103445590</pqid></control><display><type>article</type><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</creator><creatorcontrib>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</creatorcontrib><description>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE. •Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</description><identifier>ISSN: 0006-291X</identifier><identifier>ISSN: 1090-2104</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2024.150651</identifier><identifier>PMID: 39260333</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alkaloids - pharmacology ; Alkaloids - therapeutic use ; animal models ; Animals ; antioxidants ; autoimmunity ; brain ; disease severity ; EAE ; encephalitis ; Encephalomyelitis, Autoimmune, Experimental - drug therapy ; Encephalomyelitis, Autoimmune, Experimental - metabolism ; Encephalomyelitis, Autoimmune, Experimental - pathology ; Female ; Ferroptosis ; Ferroptosis - drug effects ; herbal medicines ; Inflammation ; interleukin-6 ; Matrine ; Matrines ; Mice ; Mice, Inbred C57BL ; Microglia - drug effects ; Microglia - metabolism ; Microglia - pathology ; neurodegenerative diseases ; neuroglia ; Oxidative stress ; Oxidative Stress - drug effects ; pathogenesis ; phenotype ; Quinolizines - pharmacology ; Quinolizines - therapeutic use ; sclerosis ; therapeutics</subject><ispartof>Biochemical and biophysical research communications, 2024-11, Vol.735, p.150651, Article 150651</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</cites><orcidid>0009-0007-4640-7470</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006291X24011872$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39260333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Furui</creatorcontrib><creatorcontrib>Li, Xinyu</creatorcontrib><creatorcontrib>Wang, Wenbin</creatorcontrib><creatorcontrib>Dou, Mengmeng</creatorcontrib><creatorcontrib>Li, Silu</creatorcontrib><creatorcontrib>Jin, Xin</creatorcontrib><creatorcontrib>Chu, Yaojuan</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE. •Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</description><subject>Alkaloids - pharmacology</subject><subject>Alkaloids - therapeutic use</subject><subject>animal models</subject><subject>Animals</subject><subject>antioxidants</subject><subject>autoimmunity</subject><subject>brain</subject><subject>disease severity</subject><subject>EAE</subject><subject>encephalitis</subject><subject>Encephalomyelitis, Autoimmune, Experimental - drug therapy</subject><subject>Encephalomyelitis, Autoimmune, Experimental - metabolism</subject><subject>Encephalomyelitis, Autoimmune, Experimental - pathology</subject><subject>Female</subject><subject>Ferroptosis</subject><subject>Ferroptosis - drug effects</subject><subject>herbal medicines</subject><subject>Inflammation</subject><subject>interleukin-6</subject><subject>Matrine</subject><subject>Matrines</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>neurodegenerative diseases</subject><subject>neuroglia</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>pathogenesis</subject><subject>phenotype</subject><subject>Quinolizines - pharmacology</subject><subject>Quinolizines - therapeutic use</subject><subject>sclerosis</subject><subject>therapeutics</subject><issn>0006-291X</issn><issn>1090-2104</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1P3DAURS1UBMPHH2CBsuwmw7OdeGKJDUK0RaLqBiR2luO8zHjkxKntVPDv69FMWaKu3ubcK717CLmisKRAxc122bbBLBmwaklrEDU9IgsKEkpGofpCFgAgSibp6yk5i3ELQGkl5Ak55ZIJ4JwviPupU7AjFlPwCU2KhV5rO8ZU4NuEwQ44Ju0KPSdvh2HOII4Gp412fnhHZ5ONRdoEP683xeC72elkx3UxWBP82tkc7TEEPyUfbbwgx712ES8P95y8fHt4vv9RPv36_nh_91QatoJUtpxyCW3dr6iWIA1vddXU0gBrWiOAgdENW1VSG95kxHRMtNqIvpemEVoIfk6-7nvzU79njEkNNhp0To_o56g4rStaS874f6DAq6quJWSU7dH8WowBezXlfXR4VxTUTojaqp0QtROi9kJy6PrQP7cDdh-RfwYycLsHMA_yx2JQ0djdxp0N2YfqvP2s_y8SKZ7R</recordid><startdate>20241126</startdate><enddate>20241126</enddate><creator>Feng, Furui</creator><creator>Li, Xinyu</creator><creator>Wang, Wenbin</creator><creator>Dou, Mengmeng</creator><creator>Li, Silu</creator><creator>Jin, Xin</creator><creator>Chu, Yaojuan</creator><creator>Zhu, Lin</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0009-0007-4640-7470</orcidid></search><sort><creationdate>20241126</creationdate><title>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</title><author>Feng, Furui ; Li, Xinyu ; Wang, Wenbin ; Dou, Mengmeng ; Li, Silu ; Jin, Xin ; Chu, Yaojuan ; Zhu, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-b31390b5f71a909c3ba4859c028bc6020ca82749ac3871acd26bac6ff9c86a663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alkaloids - pharmacology</topic><topic>Alkaloids - therapeutic use</topic><topic>animal models</topic><topic>Animals</topic><topic>antioxidants</topic><topic>autoimmunity</topic><topic>brain</topic><topic>disease severity</topic><topic>EAE</topic><topic>encephalitis</topic><topic>Encephalomyelitis, Autoimmune, Experimental - drug therapy</topic><topic>Encephalomyelitis, Autoimmune, Experimental - metabolism</topic><topic>Encephalomyelitis, Autoimmune, Experimental - pathology</topic><topic>Female</topic><topic>Ferroptosis</topic><topic>Ferroptosis - drug effects</topic><topic>herbal medicines</topic><topic>Inflammation</topic><topic>interleukin-6</topic><topic>Matrine</topic><topic>Matrines</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>neurodegenerative diseases</topic><topic>neuroglia</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>pathogenesis</topic><topic>phenotype</topic><topic>Quinolizines - pharmacology</topic><topic>Quinolizines - therapeutic use</topic><topic>sclerosis</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Furui</creatorcontrib><creatorcontrib>Li, Xinyu</creatorcontrib><creatorcontrib>Wang, Wenbin</creatorcontrib><creatorcontrib>Dou, Mengmeng</creatorcontrib><creatorcontrib>Li, Silu</creatorcontrib><creatorcontrib>Jin, Xin</creatorcontrib><creatorcontrib>Chu, Yaojuan</creatorcontrib><creatorcontrib>Zhu, Lin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Furui</au><au>Li, Xinyu</au><au>Wang, Wenbin</au><au>Dou, Mengmeng</au><au>Li, Silu</au><au>Jin, Xin</au><au>Chu, Yaojuan</au><au>Zhu, Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2024-11-26</date><risdate>2024</risdate><volume>735</volume><spage>150651</spage><pages>150651-</pages><artnum>150651</artnum><issn>0006-291X</issn><issn>1090-2104</issn><eissn>1090-2104</eissn><abstract>Multiple sclerosis (MS) is an inflammatory demyelination neurodegenerative disease of the central nervous system (CNS). Ferroptosis has been implicated in a range of brain disorders, and iron-loaded microglia are frequently found in affected brain regions. However, the molecular mechanisms linking ferroptosis with MS have not been well-defined. The present study seeks to bridge this gap and investigate the impact of matrine (MAT), a herbal medicine with immunomodulatory capacities, on the regulation of oxidative stress and ferroptosis in the CNS of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS. CNS of EAE mice contained elevated levels of ferroptosis-related molecules, e.g., MDA, LPCAT3 and PTGS2, but decreased expression of antioxidant molecules, including GSH and SOD, GPX4 and SLC7A11. This pathogenic process was reversed by MAT treatment, together with significant reduction of disease severity and CNS inflammatory demyelination. Furthermore, the expression of PTGS2 and LOX was largely increased in microglia of EAE mice, accompanied with increased production of IL-6 and TNF-α, indicating a proinflammatory phenotype of microglia that undergo oxidative stress/ferroptosis, and their expression was significantly reduced after MAT treatment. Together, our results indicate that ferroptosis/inflammation plays an important role in the pathogenesis of CNS autoimmunity, and inhibiting ferroptosis-induced microglial activation/inflammation could be a novel mechanism underlying the therapeutic effects of MAT on CNS inflammatory demyelination in EAE. •Multiple indicators of ferroptosis have been validated to occur in the EAE model, providing a basis for potential therapeutic targets for multiple sclerosis.•Matrine repairs the SLC7A11-GPX4 axis damage induced by the EAE model.•Matrine mitigated oxidative stress and attenuated inflammation in an EAE model.•Matrine can inhibit lipid peroxidation and protect microglia from ferroptosis in EAE model.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39260333</pmid><doi>10.1016/j.bbrc.2024.150651</doi><orcidid>https://orcid.org/0009-0007-4640-7470</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2024-11, Vol.735, p.150651, Article 150651
issn 0006-291X
1090-2104
1090-2104
language eng
recordid cdi_proquest_miscellaneous_3154159323
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Alkaloids - pharmacology
Alkaloids - therapeutic use
animal models
Animals
antioxidants
autoimmunity
brain
disease severity
EAE
encephalitis
Encephalomyelitis, Autoimmune, Experimental - drug therapy
Encephalomyelitis, Autoimmune, Experimental - metabolism
Encephalomyelitis, Autoimmune, Experimental - pathology
Female
Ferroptosis
Ferroptosis - drug effects
herbal medicines
Inflammation
interleukin-6
Matrine
Matrines
Mice
Mice, Inbred C57BL
Microglia - drug effects
Microglia - metabolism
Microglia - pathology
neurodegenerative diseases
neuroglia
Oxidative stress
Oxidative Stress - drug effects
pathogenesis
phenotype
Quinolizines - pharmacology
Quinolizines - therapeutic use
sclerosis
therapeutics
title Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T20%3A22%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Matrine%20protects%20against%20experimental%20autoimmune%20encephalomyelitis%20through%20modulating%20microglial%20ferroptosis&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Feng,%20Furui&rft.date=2024-11-26&rft.volume=735&rft.spage=150651&rft.pages=150651-&rft.artnum=150651&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2024.150651&rft_dat=%3Cproquest_cross%3E3103445590%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3103445590&rft_id=info:pmid/39260333&rft_els_id=S0006291X24011872&rfr_iscdi=true